Original Research
Published on 03 Oct 2022
The proteolysis targeting chimera GMB-475 combined with dasatinib for the treatment of chronic myeloid leukemia with BCR::ABL1 mutants
in Pharmacology of Anti-Cancer Drugs
- 4,512 views
- 3 citations
Original Research
Published on 03 Oct 2022
in Pharmacology of Anti-Cancer Drugs
Brief Research Report
Published on 06 Aug 2025
in Embryonic Development
Original Research
Published on 11 Aug 2020
in Cancer Genetics
Original Research
Published on 25 Aug 2022
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 20 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 19 Nov 2021
in Obstetric and Pediatric Pharmacology
Original Research
Published on 26 Mar 2013
Original Research
Published on 10 Jan 2023
in Computational Genomics
Original Research
Published on 30 Jun 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 27 Jul 2022
in Pediatric Hematology and Hematological Malignancies
Case Report
Published on 24 Oct 2025
in Hematologic Malignancies
Original Research
Published on 07 Aug 2020
in Hematologic Malignancies
Case Report
Published on 13 Aug 2025
in Hematologic Malignancies
Case Report
Published on 30 Nov 2022
in Pediatric Cardiology
Original Research
Published on 06 Jan 2025
in Livestock Genomics
Review
Published on 06 Sep 2019
in Hematologic Malignancies